P16-48. Immunologic and virologic characterization of an ART-treated HIV-1 patients cohort with long-term control of viremia by Kinloch, S et al.
BioMed  Central
Page 1 of 1
(page number not for citation purposes)
Retrovirology
Open Access Poster presentation
P16-48. Immunologic and virologic characterization of an 
ART-treated HIV-1 patients cohort with long-term control of 
viremia
S Kinloch1, C Cellerai*2, S Yerly3, P Byrne4, A Carroll4, H Stauss1, A Johnson1, 
A Harari2 and G Pantaleo2
Address: 1Royal Free and University College School of Medicine, London, UK, 2Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland, 
3Hôpitaux Universitaires de Genève, Geneva, Switzerland and 4Royal Free Hospital, London, UK
* Corresponding author    
Background
Long-term treatment of primary HIV-1 infection (PHI)
may allow the immune reconstitution of responses lost
during the acute viremic phase and decrease of peripheral
reservoirs. This in turn may represent the best setting for
the use of therapeutic vaccines in order to lower the viral
set-point or control of viral rebound upon ART discontin-
uation.
Methods
We investigated a cohort of 16 patients who started ART at
PHI, with treatment duration of ≥4 years and persistent
aviremia (<50 HIV-1 copies/ml). The cohort was charac-
terized in terms of viral subtype, cell-associated RNA, pro-
viral DNA and HLA genotype. Secretion of IFN-γ, IL-2 and
TNF-α by CD8 T-cells was analysed by polychromatic
flowcytometry using a panel of 192 HIV-1-derived
epitopes.
Results
This cohort is highly homogenous in terms of viral sub-
type: 81% clade B. We identified 44 epitope-specific
responses: all patients had detectable responses to >1
epitope and the mean number of responding epitopes per
patient was 3. The mean frequency of cytokines-secreting
CD8 T-cells was 0.32%. CD8 T-cells secreting simultane-
ously IFN-γ, IL-2 and TNF-α made up for about 40% of
the response and cells secreting at least 2 cytokines for
about 80%, consistent with a highly polyfunctional CD8
T-cell profile. There was no difference in term of polyfunc-
tionality when HLA restriction, or recognized viral regions
and epitopes were considered. Proviral DNA was detecta-
ble in all patients but at low levels (mean = 108 copies/1
million PBMCs) while cell-associated mRNA was not
detectable in 19% of patients (mean = 11 copies/1 million
PBMCs when detectable).
Conclusion
Patients with sustained virological suppression after initi-
ation of ART at PHI show polyfunctional CD8 T-cell and
low levels of proviral DNA with an absence of residual
replication in a substantial percentage of patients. The use
of therapeutic vaccines in this population may promote
low level of rebound viremia or control of viral replication
upon ART cessation.
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